课题基金 / 基金详情

项目摘要

项目成果

SANDEEP Kumar TRIPATHY的其他基金

相关文献

中文摘要
翻译
描述(由申请人提供):自然杀伤(NK)细胞杀死异常细胞并产生细胞因子和趋化因子的能力使其能够参与对病毒和肿瘤的初始防御,并影响随后的适应性免疫应答。为了防止无意的组织破坏,NK细胞不仅经历“教育”过程以确保它们对健康的“自身”细胞具有耐受性,而且还显示出响应环境影响和调节NK细胞效应器应答的适应性特性。我们证明了NK细胞上活化受体的持续参与导致诱导的低反应性(耐受性)。这些研究使用了一种新型转基因小鼠(m157-Tg),该小鼠表达鼠巨细胞病毒(MCMV)编码的m157蛋白(NK细胞特异性活化受体Ly 49 H的唯一已知配体),并证明了Ly 49 H + NK细胞群体的低反应性。m157-Tg小鼠中的耐受性Ly 49 H + NK细胞的特征在于响应于通过非Ly 49 H活化受体的刺激而受损的细胞因子产生和脱粒。活化受体调节NK细胞适应性反应(诱导耐受vs活化)的机制尚不清楚。在这个提议中,我们将研究活化受体参与对NK细胞适应的作用。在该提议中要检查的核心假设是,通过NK细胞活化受体的持续刺激改变通过活化受体信号传导途径的信号转导,导致NK细胞的耐受状态而不是活化状态。这一假设的具体目的是(1)确定Ly 49 H接合向NK细胞传递抑制信号的机制,(2)评估耐受性NK细胞的非Ly 49 H活化受体的信号传导变化,以及(3)定义m157/Ly 49 H相互作用导致体内NK细胞耐受性的背景。 公共卫生相关性:自然杀伤(NK)细胞在血液中循环,几乎存在于所有器官中,在那里它们准备消除应激,病毒感染或转化细胞而无需事先致敏。这些属性已经导致尝试设计针对人类癌症和病毒感染的潜在的基于NK细胞的免疫策略。最近的研究表明,NK细胞具有适应其环境并改变其效应反应的能力。本提案中描述的研究将帮助我们了解NK细胞适应的机制,如果我们要在未来的免疫策略中利用NK细胞的能力,这将是至关重要的。
英文摘要
DESCRIPTION (provided by applicant): The ability of natural killer (NK) cells to kill abnormal cells and produce cytokines and chemokines allows them to participate in the initial defense against viruses and tumors, as well as influence the subsequent adaptive immune response. In order to prevent inadvertent tissue destruction, NK cells not only undergo an "education" process to ensure they are tolerant to healthy "self" cells, but also display adaptive properties that respond to environmental influences and modulate NK cell effector response. We demonstrated that continuous engagement of an activating receptor on the NK cell results in an induced hyporesponsiveness (tolerance). Those studies utilized a novel transgenic mouse (m157-Tg) that expresses the murine cytomegalovirus (MCMV) encoded m157 protein (the only known ligand for the NK cell-specific activating receptor Ly49H) and demonstrated a hyporesponsiveness in the Ly49H+ NK cell population. Tolerant Ly49H+ NK cells in the m157-Tg mouse were characterized by impaired cytokine production and degranulation in response to stimulation through non-Ly49H activating receptors. The mechanism(s) by which activating receptors modulate NK cell adaptive responses (induction of tolerance versus activation) are not understood. In this proposal we will investigate the role of activating receptor engagement on NK cell adaptation. The core hypothesis to be examined in this proposal is that persistent stimulation through NK cell activating receptors alters signal transduction through the activating receptor signaling pathway, resulting in a tolerant rather than activated state of the NK cell. The specific aims to this hypothesis will (1) determine the mechanism by which Ly49H engagement delivers an inhibitory signal to NK cells, (2) evaluate signaling changes in non-Ly49H activating receptors from tolerant NK cells, and (3) define the context by which m157/Ly49H interaction results in NK cell tolerance in vivo. PUBLIC HEALTH RELEVANCE: Natural killer (NK) cells circulate through the blood and are present in virtually all organs, where they are poised to eliminate stressed, virally infected, or transformed cells without prior sensitization. These attributes have led to attempts to design potential NK-cell-based immunotherapeutic strategies against human cancer and viral infections. Recent studies suggest that NK cells have the capacity to adapt to their environment and alter their effector response. Studies described in this proposal will help us understand mechanism(s) of NK cell adaptation, which will be essential if we are to harness the capabilities of NK cells in future immunotherapeutic strategies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
MECHANISMS OF NATURAL KILLER CELL TOLERANCE
  • 批准号:
    8306743
  • 项目类别:
  • 资助金额:
    $38.0万
  • 财政年份:
    2011
  • 负责人:
    SANDEEP Kumar TRIPATHY
  • 依托单位:
MECHANISMS OF NATURAL KILLER CELL TOLERANCE
  • 批准号:
    8481509
  • 项目类别:
  • 资助金额:
    $35.72万
  • 财政年份:
    2011
  • 负责人:
    SANDEEP Kumar TRIPATHY
  • 依托单位:
MECHANISMS OF NATURAL KILLER CELL TOLERANCE
  • 批准号:
    8680002
  • 项目类别:
  • 资助金额:
    $38.0万
  • 财政年份:
    2011
  • 负责人:
    SANDEEP Kumar TRIPATHY
  • 依托单位:
The Role of Activating Receptors in Natural Killer Cell Development
  • 批准号:
    7134310
  • 项目类别:
  • 资助金额:
    $11.93万
  • 财政年份:
    2006
  • 负责人:
    SANDEEP Kumar TRIPATHY
  • 依托单位: